This information is accurate as of 04/6/2026. Please refer back to the website to ensure all reference information is current and up-to-date.

News

April 27, 2022

CDC: Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19

April 27, 2022

The Conversation: COVID-19 vaccines for the youngest children may be inching closer to authorization – a pediatrician explains how they’re being tested

April 14, 2022

ATAGI statement on use of booster doses in adolescents aged 12-15 years

April 14, 2022

Science: Pandemic propels global effort to study rare vaccine side effects

April 14, 2022

New immunisation reference page: Diphtheria

April 14, 2022

ATAGI advice on use of sedation for COVID-19 vaccination

April 13, 2022

Registrations now open for the April CVU mini event

March 31, 2022

Moderna: COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to ≤ 6 Years successfully meets its primary endpoint

March 30, 2022

ATAGI clinical guidance on Japanese encephalitis virus vaccines

March 30, 2022

Updated immunisation reference page: Rotavirus

March 30, 2022

ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine

March 24, 2022

Sydney Institute for Infectious Diseases webinar recording now available: JEV outbreak in Australia – important insight for clinicians

March 24, 2022

Save the date for our first CVU mini event for 2022: Thursday 28 April 2022

March 24, 2022

Vocal cord dysfunction/inducible laryngeal obstruction(s) mimicking anaphylaxis during SARS-CoV-2 (COVID-19) vaccination

March 24, 2022

Updated immunisation reference pages: Influenza and Influenza vaccine: frequently asked questions

March 17, 2022

The Conversation: Flu, COVID and flurona: what we can and can’t expect this winter

March 17, 2022

The New York Times: In Africa, a Mix of Shots Drives an Uncertain Covid Vaccination Push

March 17, 2022

CDC: Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

About MVEC

The Melbourne Vaccine Education Centre (MVEC) is an educational website, developed with the aim of providing up-to-date immunisation information for both healthcare professionals and members of the public. We are based at Murdoch Children’s Research Institute (MCRI), a research organisation, and are affiliated with SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), the Victorian Vaccine Safety Service.

Latest news

June 4, 2026

NIP: Adult pneumococcal vaccination – Program advice for health professionals
June 4, 2026

Immunisation Coalition: Vale: Prof Allan Cripps memorial tribute webinar on pneumococcal disease
Share This